Rat serum electrolytes, lipid profile and cardiovascular activity on Nauclea latifolia leaf extract administration

Indian Journal of Clinical Biochemistry

Volumn 20, Issue 2, 2005, Pages 29-34

  Akpanabiatu, M I ^a   Umoh, I B ^a   Udosen, E O ^a   Udoh, A E ^a   Edet, E E ^a  

^a UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

Cardiovascular activity; Electrolytes; Lipid profile; Nauclea latifolia

Indexed keywords

ACETYLCHOLINE; ALCOHOL; COCONUT OIL; ELECTROLYTE; LIPID; NAUCLEA LATIFOLIA EXTRACT; PHENYLEPHRINE; PLANT EXTRACT; POTASSIUM ION; SODIUM ION; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG SOLUBILITY; ELECTROLYTE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; MALE; MEDICINAL PLANT; NAUCLEA LATIFOLIA; NONHUMAN; PLANT LEAF; PLANT ROOT; POTASSIUM BLOOD LEVEL; RAT; RAT STRAIN; RUBIACEAE; SINGLE DRUG DOSE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SODIUM BLOOD LEVEL; THORACIC AORTA; VASODILATATION;

ANIMALIA; NAUCLEA LATIFOLIA; RUBIACEAE;

EID: 24044448205     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02867397     Document Type: Article

References (19)

1. Udoh, F. V. (1998) Effect of leaf and root extract of Nauclea latifolia on cardiovascular system. Fitoterapia. 69 (2), 141-146.
2. Udoh, F.V. (1995) Effects of leaf and root extracts of Nauclea latifolia purinergic neurotransmission in rat bladder. Phytother. Res. 9, 239-243.
3. 4 hepatotoxicity. Life Sci. 33, 401-408.
4. Niki, E. (1987) Interaction of ascorbate and α-tocopherol. Ann. NY. Acad. Sci. 498, 186-199.
5. Machlin, L.J. (1991) Vitamin E. In: Machlin, J.M. editor. Handbook of vitamins. New York: Dekker, p. 99.
6. Campillo, J.E., Torres, M.D., Dominguez, E., Romero, A. and Perez, C. (1994) Ficus carica leaf administration reduces hypertriglyceridaemia in streptozotocin diabetic rats. Diabetologia 37 (1), A213.
7. Cignarella, A., Nastasi, M., Cavalli, E. and Puglisi, L. (1998) Novel lipid lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment in several models of dyslipidaemia: a comparison with ciprofibrate. Thromb. Res. 84 (5), 311-322.
8. Dominquez, E., Canal, J.R., Torres, M.D., Campillo, J.E. and Perez, C. (1996) Hypolipidaemic activity of Ficus carica leaf extract in streptozotocin-diabetic rats. Phytother. Res. 10, 526-528.
9. Jones, P.J., Macdougall, D.E., Ntanios, F. and Vanstone, C.A. (1997) Dietary phytosterols as cholesterol lowering agents in humans. Can. J. Physiol. Pharm, 75 (3), 217-227.
10. Perez, C., Canal, J.R., Campillo, J.E. et al. (1999) Hypotriglyceridaemic activity of Fiscus carica leaves in experimental hypertriglyceridaemic rats. Phytother. Res. 13, 188-191.
11. Eno, A.E. and Owo, O.I. (1999) Cardiovascular effects of an extract from the roots of a shrub Elaeophorbia drupifera. Phytother. Res. 13, 549-554.
12. Udoh, A.E., Odigwe, C.O., Akpanabiatu, M., Ekanem, N.S. and Andy, J.J. (1990) Lipid profiles of some diabetic and non-diabetic Nigerians. Med. Sci. Res. 18, 761-762.
13. NIH consensus conference (1993) Triglyceride, high-density lipoprotein and coronary heart disease. J. Am. Med. Assoc. 269, 505-510.
14. Nurminen, M.L., Krpela, R. and Vapattalo, H. (1998) Dietary factors in the pathogenesis and treatment of hypertension. Ann. Med. 30 (2), 1433-1450.
15. Pedraza, C.J., Tapia, E., Medina, C.D., Angeles, G. M-delos, Franco, M. and Delos-Angeles-Granados, M. (1998) Garlic prevents hypertension induced by chronic inhibition of nitric oxide synthesis. Life Sci. 62 (6), 71-77.
16. Satia, M.C., Shukla, M.L. and Goyal, R.K. (1995) Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects. Ind. J. Physiol. Pharmacol. 39 (3), 237-241.
17. Heneda, T., Ido, A., Fujikane, T., Tanaka, H., Tanazawa, S. et al. (1998) Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension. Nippon-Ronen-Igakkai-Zasshi 35 (1), 33-38.
18. Scemama, M., Fevrier, B., Beucler, I. and Daurou, F. (1995) Lipid profile and antihypertensive efficacy in hyperlipidaemic hypertensive patients: Comparison of rilmenidine and captopril. J. Cardiovasc. Pharmacol. 26 (2), 34-39.
19. Lipid Research Clinics Programme (1984a) The lipid research clinics coronary primary prevention trial results, 1: reduction in the incidence of heart disease. JAMA 251, 351-364.